2024;12(3):e1224
Commonly Reported Side Effects Based on community reports, side effects appear relatively uncommon and typically mild: Most Frequently Reported: Injection site reactions (redness, minor pain, itching) Mild nausea (particularly with oral administration) Temporary dizziness Headache Fatigue Less Commonly Reported: Skin flushing Changes in appetite Temporary mood changes Vivid dreams Theoretical Concerns Growth Factor Effects: BPC-157's upregulation of growth factors raises theoretical concerns for: Cancer promotion in those with existing malignancies Acceleration of undiagnosed tumors Effects on benign growths (polyps, fibroids) No evidence directly supports these concerns, but caution is warranted given the mechanisms involved
This Hospira Pfizer formulation (NDC 0409-3977-03) is the same pharmaceutical-grade product used in hospitals, clinics, compounding pharmacies, and institutional settings nationwide
Bioavailability study of an innovative orobuccal formulation of glutathione
3B) and intracellular survival (Fig
Results vary based on your age, your current health status, and your environmental exposures
